Literature DB >> 12548208

Endometritis does not predict reproductive morbidity after pelvic inflammatory disease.

Catherine L Haggerty1, Roberta B Ness, Antonio Amortegui, Susan L Hendrix, Sharon L Hillier, Robert L Holley, Jeffrey Peipert, Hugh Randall, Steven J Sondheimer, David E Soper, Richard L Sweet, Guiliana Trucco.   

Abstract

OBJECTIVE: We investigated the association between endometritis and reproductive morbidity. STUDY
DESIGN: Participants were 614 women in the PID Evaluation and Clinical Health (PEACH) Study with pelvic pain, pelvic organ tenderness, and leukorrhea, mucopurulent cervicitis, or untreated cervicitis. We compared women with endometritis (>or=5 neutrophils or >or=2 plasma cells), Neisseria gonorrhoeae or Chlamydia trachomatis upper genital tract infection (UGTI) or both to women without endometritis/UGTI for outcomes of pregnancy, infertility, recurrent pelvic inflammatory disease (PID), and chronic pelvic pain (CPP), adjusting for age, race, education, PID history, and baseline infertility.
RESULTS: Endometritis/UGTI was not associated with reduced pregnancy (odds ratio [OR] 0.8, 95% CI 0.6-1.2) or elevated infertility (OR 1.0, 95% CI 0.6-1.6), recurrent PID (OR 0.6, 95% CI 0.4-0.9), or CPP (OR 0.6, 95% CI 0.4-0.9). PEACH participants with and without endometritis/UGTI had higher age- and race-specific pregnancy rates than 1997 national rates.
CONCLUSION: Among women with clinically suspected mild-to-moderate PID treated with standard antibiotics, endometritis/UGTI was not associated with reproductive morbidity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12548208     DOI: 10.1067/mob.2003.87

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  22 in total

1.  Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial.

Authors:  J D C Ross; H S Cronjé; T Paszkowski; I Rakoczi; D Vildaite; A Kureishi; M Alefelder; P Arvis; P Reimnitz
Journal:  Sex Transm Infect       Date:  2006-05-24       Impact factor: 3.519

2.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

3.  Racial variation in toll-like receptor variants among women with pelvic inflammatory disease.

Authors:  Brandie D Taylor; Toni Darville; Robert E Ferrell; Roberta B Ness; Catherine L Haggerty
Journal:  J Infect Dis       Date:  2012-12-18       Impact factor: 5.226

4.  Microbial correlates of delayed care for pelvic inflammatory disease.

Authors:  Brandie D Taylor; Roberta B Ness; Toni Darville; Catherine L Haggerty
Journal:  Sex Transm Dis       Date:  2011-05       Impact factor: 2.830

5.  Placental C4d as a common feature of chromosomally normal and abnormal miscarriages.

Authors:  Joong Yeup Lee; Joon-Seok Hong; Eun Na Kim; Soyeon Ahn; Jin Choe; Doyeong Hwang; Ki Chul Kim; Seok Hyun Kim; Chong Jai Kim
Journal:  Virchows Arch       Date:  2014-03-27       Impact factor: 4.064

6.  Endometrial leukocyte subpopulations associated with Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis genital tract infection.

Authors:  Seth D Reighard; Richard L Sweet; Claudia Vicetti Miguel; Rodolfo D Vicetti Miguel; Mamatha Chivukula; Uma Krishnamurti; Thomas L Cherpes
Journal:  Am J Obstet Gynecol       Date:  2011-05-20       Impact factor: 8.661

7.  Limitations of the criteria used to diagnose histologic endometritis in epidemiologic pelvic inflammatory disease research.

Authors:  Rodolfo D Vicetti Miguel; Mamatha Chivukula; Uma Krishnamurti; Antonio J Amortegui; Jeffrey A Kant; Richard L Sweet; Harold C Wiesenfeld; Jaclyn M Phillips; Thomas L Cherpes
Journal:  Pathol Res Pract       Date:  2011-10-13       Impact factor: 3.250

8.  Stimulating an immune response? Oral sex is associated with less endometritis.

Authors:  R Pittrof; E Sully; D C Bass; S F Kelsey; R B Ness; C L Haggerty
Journal:  Int J STD AIDS       Date:  2012-11       Impact factor: 1.359

9.  Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease?

Authors:  Gail M Trautmann; Kevin E Kip; Holly E Richter; David E Soper; Jeffrey F Peipert; Deborah B Nelson; Wayne Trout; Dianne Schubeck; Debra C Bass; Roberta B Ness
Journal:  Am J Obstet Gynecol       Date:  2008-01       Impact factor: 8.661

10.  Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease.

Authors:  Vanessa L Short; Patricia A Totten; Roberta B Ness; Sabina G Astete; Sheryl F Kelsey; Catherine L Haggerty
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.